| Population pharmacokinetic models were used to explore the pharmacokinetics of sunitinib in children with gastrointestinal stromal tumors or other solid tumors |
| Based on the final model, a dose of approximately 20 mg/m2/day in children with gastrointestinal stromal tumors would be expected to lead to similar levels of sunitinib as in adults receiving the daily approved dose |
| This study provides new data to guide sunitinib dosing in children |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.